BioAdaptives, Inc. (BDPT) stock
BDPTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00−0.00 (-5.56%)
Close on Oct 19, 2026Market cap $478.03KP/E –Yield –
BioAdaptives cash
Cash and short-term investments held at the end of each period.
BioAdaptives's cash was $29.22K at Jun 30, 2026. For fiscal 2025 it was $158.45K, up 15.3% from the year before. Over ten years it grew 8.8% a year on average. The highest annual figure on record is $158.45K in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $158.45K | +15.3% |
| FY2024 | Dec 31, 2024 | $137.47K | +126.2% |
| FY2023 | Dec 31, 2023 | $60.78K | +138.8% |
| FY2022 | Dec 31, 2022 | $25.45K | -69.4% |
| FY2021 | Dec 31, 2021 | $83.13K | +1552.3% |
| FY2020 | Dec 31, 2020 | $5.03K | -61.6% |
| FY2019 | Dec 31, 2019 | $13.09K | -78.3% |
| FY2018 | Dec 31, 2018 | $60.20K | +16622.8% |
| FY2017 | Dec 31, 2017 | $360 | -92.7% |
| FY2015 | Dec 31, 2015 | $4.96K | -92.7% |
| FY2014 | Dec 31, 2014 | $68.01K | -42.7% |
| FY2013 | Dec 31, 2013 | $118.61K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $29.22K | -86.1% |
| Q1 FY2026 | Mar 31, 2026 | $73.61K | +86.0% |
| Q4 FY2025 | Dec 31, 2025 | $158.45K | +15.3% |
| Q3 FY2025 | Sep 30, 2025 | $59.27K | +35.0% |
| Q2 FY2025 | Jun 30, 2025 | $210.58K | +89509.4% |
| Q1 FY2025 | Mar 31, 2025 | $39.56K | +101.9% |
| Q4 FY2024 | Dec 31, 2024 | $137.47K | +126.2% |
| Q3 FY2024 | Sep 30, 2024 | $43.89K | -71.1% |
| Q2 FY2024 | Jun 30, 2024 | $235 | -99.4% |
| Q1 FY2024 | Mar 31, 2024 | $19.60K | +227.9% |
| Q4 FY2023 | Dec 31, 2023 | $60.78K | +138.8% |
| Q3 FY2023 | Sep 30, 2023 | $152.08K | +677.4% |
| Q2 FY2023 | Jun 30, 2023 | $40.14K | -9.8% |
| Q1 FY2023 | Mar 31, 2023 | $5.98K | -89.3% |
| Q4 FY2022 | Dec 31, 2022 | $25.45K | -69.4% |
| Q3 FY2022 | Sep 30, 2022 | $19.56K | -70.7% |
| Q2 FY2022 | Jun 30, 2022 | $44.51K | -36.7% |
| Q1 FY2022 | Mar 31, 2022 | $55.96K | +103.5% |
| Q4 FY2021 | Dec 31, 2021 | $83.13K | +1552.3% |
| Q3 FY2021 | Sep 30, 2021 | $66.68K | +349.3% |
| Q2 FY2021 | Jun 30, 2021 | $70.27K | +1630.0% |
| Q1 FY2021 | Mar 31, 2021 | $27.50K | +128.0% |
| Q4 FY2020 | Dec 31, 2020 | $5.03K | -61.6% |
| Q3 FY2020 | Sep 30, 2020 | $14.84K | +919.2% |
| Q2 FY2020 | Jun 30, 2020 | $4.06K | -70.1% |
| Q1 FY2020 | Mar 31, 2020 | $12.06K | -37.6% |
| Q4 FY2019 | Dec 31, 2019 | $13.09K | -78.3% |
| Q3 FY2019 | Sep 30, 2019 | $1.46K | -99.2% |
| Q2 FY2019 | Jun 30, 2019 | $13.57K | +3669.2% |
| Q1 FY2019 | Mar 31, 2019 | $19.32K | +30.0% |
| Q4 FY2018 | Dec 31, 2018 | $60.20K | +1937.3% |
| Q2 FY2018 | Jun 30, 2018 | $180.51K | +3066.3% |
| Q4 FY2017 | Dec 31, 2017 | $360 | -92.7% |
| Q3 FY2016 | Sep 30, 2016 | $14.86K | +162.5% |
| Q2 FY2016 | Jun 30, 2016 | $2.96K | – |
| Q1 FY2016 | Mar 31, 2016 | $5.70K | – |
| Q4 FY2015 | Dec 31, 2015 | $4.96K | – |
| Q3 FY2015 | Sep 30, 2015 | $5.66K | – |
See a number that looks wrong?